Paper35411997
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.
Davies MA and 46 others. Trop Med Int Health, 2022. Cited by 109 papers, by iCite.
Cite this record
ConductScience Library. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. Papers, record 35411997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35411997
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Clinical Laboratory Techniques | Major topic |
| SARS-CoV-2 | Major topic |
| Adult | |
| COVID-19 Testing | |
| COVID-19 Vaccines | |
| Cohort Studies | |
| Female | |
| Humans | |
| Male | |
| Seroepidemiologic Studies | |
| South Africa | |
| Young Adult |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 203135/Z/16/Z | Wellcome Trust | United Kingdom | PubMed | PubMed | |
| FC0010218 | Wellcome Trust | United Kingdom | PubMed | PubMed | |
| INV-017293 | Gates Foundation | United States | PubMed | PubMed | |
| R01 HD080465 | NICHD NIH HHS | United States | R01HD080465 | PubMed and NIH | NIH RePORTER |
| 1191327 | Gates Foundation | United States | PubMed | PubMed | |
| 1164272 | Gates Foundation | United States | PubMed | PubMed | |
| 214321/Z/18/Z | Wellcome Trust | United Kingdom | PubMed | PubMed | |
| FC0010218 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| FC0010218 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| 222574 | Wellcome Trust | United Kingdom | PubMed | PubMed | |
| U01 AI069924 | NIAID NIH HHS | United States | U01AI069924 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 35043121 |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35411997 | Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. | Trop Med Int Health | 2022 | https://conductscience.org/library/papers/35411997 | PubMed |
| 2 | 34882437 | Track Omicron's spread with molecular data. | Science | 2021 | https://conductscience.org/library/papers/34882437 | PubMed |
| 3 | 34967859 | Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves. | JAMA | 2022 | https://conductscience.org/library/papers/34967859 | PubMed |
| 4 | 34487704 | Hospitalisation associated with SARS-CoV-2 delta variant in Denmark. | Lancet Infect Dis | 2021 | https://conductscience.org/library/papers/34487704 | PubMed |
| 5 | 35289632 | Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. | Science | 2022 | https://conductscience.org/library/papers/35289632 | PubMed |
| 6 | 34286217 | Higher COVID-19 mortality in low-income communities in the City of Cape Town - a descriptive ecological study. | Gates Open Res | 2021 | https://conductscience.org/library/papers/34286217 | PubMed |
| 7 | 34252381 | Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. | Lancet Glob Health | 2021 | https://conductscience.org/library/papers/34252381 | PubMed |
| 8 | 32860699 | Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32860699 | PubMed |
| 9 | 37994361 | Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study. | Gates Open Res | 2022 | https://conductscience.org/library/papers/37994361 | PubMed |
| 10 | 35062015 | SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. | Nature | 2022 | https://conductscience.org/library/papers/35062015 | PubMed |
| 11 | 35066015 | The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters. | Antiviral Res | 2022 | https://conductscience.org/library/papers/35066015 | PubMed |
| 12 | 35196424 | Population Immunity and Covid-19 Severity with Omicron Variant in South Africa. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35196424 | PubMed |
| 13 | 34461056 | Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/34461056 | PubMed |
| 14 | 35042229 | Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. | Nature | 2022 | https://conductscience.org/library/papers/35042229 | PubMed |
| 15 | 32935043 | Data Centre Profile: The Provincial Health Data Centre of the Western Cape Province, South Africa. | Int J Popul Data Sci | 2019 | https://conductscience.org/library/papers/32935043 | PubMed |
| 16 | 34423834 | Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta). | Clin Infect Dis | 2022 | https://conductscience.org/library/papers/34423834 | PubMed |
| 17 | 35104837 | Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. | Nature | 2022 | https://conductscience.org/library/papers/35104837 | PubMed |
| 18 | 34477548 | SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021. | Emerg Infect Dis | 2021 | https://conductscience.org/library/papers/34477548 | PubMed |
| 19 | 35065011 | Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. | Lancet | 2022 | https://conductscience.org/library/papers/35065011 | PubMed |
Cited by95
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41264585 | Concern for severe COVID-19 disease during the initial two years of pandemic in a rural South African community: A population-based study. | PLoS One | 2025 | https://conductscience.org/library/papers/41264585 | PubMed |
| 40872876 | Challenges to the Effectiveness and Immunogenicity of COVID-19 Vaccines: A Narrative Review with a Systematic Approach. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40872876 | PubMed |
| 40057834 | Clinical characterisation, treatment outcomes, and case fatality risk of patients with different SARS-CoV-2 variants in Bangladesh. | J Glob Health | 2024 | https://conductscience.org/library/papers/40057834 | PubMed |
| 39758969 | Increased gastrointestinal bleeding-related mortality during the COVID-19 pandemic. | Ther Adv Gastroenterol | 2025 | https://conductscience.org/library/papers/39758969 | PubMed |
| 39593005 | Clinical characteristics and booster vaccine effectiveness of the Omicron variant. | BMC Infect Dis | 2024 | https://conductscience.org/library/papers/39593005 | PubMed |
| 39578871 | Clinical outcomes of Omicron infection and vaccine acceptance among pediatric liver transplant recipients: insights from a cross-sectional survey. | Virol J | 2024 | https://conductscience.org/library/papers/39578871 | PubMed |
| 39106267 | SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities. | PLOS Glob Public Health | 2024 | https://conductscience.org/library/papers/39106267 | PubMed |
| 39090598 | Acute and long COVID-19 symptoms and associated factors in the omicron-dominant period: a nationwide survey via the online platform Wenjuanxing in China. | BMC Public Health | 2024 | https://conductscience.org/library/papers/39090598 | PubMed |
| 39020307 | A prospective randomised controlled trial investigating household SARS-CoV-2 transmission in a densely populated community in Cape Town, South Africa - the transmission of COVID-19 in crowded environments (TRACE) study. | BMC Public Health | 2024 | https://conductscience.org/library/papers/39020307 | PubMed |
| 38971737 | Impact of non-emergency surgical timing on postoperative recovery quality in mild or asymptomatic SARS-CoV-2 infected patients: a grouped cohort study. | BMC Anesthesiol | 2024 | https://conductscience.org/library/papers/38971737 | PubMed |
| 38742290 | Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective Study. | J Korean Med Sci | 2024 | https://conductscience.org/library/papers/38742290 | PubMed |
| 38675745 | SARS-CoV-2 Neutralizing Antibodies in Three African Countries Following Multiple Distinct Immune Challenges. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38675745 | PubMed |
| 38450129 | Comparing COVID-19 severity in patients hospitalized for community-associated Delta, BA.1 and BA.4/5 variant infection. | Front Public Health | 2024 | https://conductscience.org/library/papers/38450129 | PubMed |
| 38157194 | Pathogen evolution, prevention/control strategy and clinical features of COVID-19: experiences from China. | Front Med | 2023 | https://conductscience.org/library/papers/38157194 | PubMed |
| 37994361 | Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study. | Gates Open Res | 2022 | https://conductscience.org/library/papers/37994361 | PubMed |
| 37907849 | Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service. | BMC Infect Dis | 2023 | https://conductscience.org/library/papers/37907849 | PubMed |
| 37821945 | Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity. | Eur J Med Res | 2023 | https://conductscience.org/library/papers/37821945 | PubMed |
| 37766248 | Seven Epidemic Waves of COVID-19 in a Hospital in Madrid: Analysis of Severity and Associated Factors. | Viruses | 2023 | https://conductscience.org/library/papers/37766248 | PubMed |
| 37748932 | A risk science perspective on vaccines. | Risk Anal | 2024 | https://conductscience.org/library/papers/37748932 | PubMed |
| 37738280 | Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four waves. | PLoS One | 2023 | https://conductscience.org/library/papers/37738280 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35411997
GET https://conductscience.org/api/papers/v1/35411997/authors?page=2